GNTA logo

Genenta Science S.p.A. American Depositary Shares


GNTA: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.


Show GNTA Financials

Consumer Interest
SEC Filings

Recent trades of GNTA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by GNTA's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GNTA in WallStreetBets Daily Discussion


Recent insights relating to GNTA

CNBC Recommendations

Recent picks made for GNTA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GNTA

Corporate Flights

Flights by private jets registered to GNTA